Thursday, January 19, 2017 6:56:00 PM
With all the forward looking statements with intent outlined most of the way, did anyone recognize the missteps as such, or are we talking hind-sight? I am sure I didn't identify any mistakes, as they were happening. If Kim doesn't have business acumen, is it genuine to criticize now? The drum has been beating critical of Kim for many months and weeks. I don't remember those drums being beat while the steps being characterized as missteps now, were being made. I am not even sure of specific business decisions that we are speaking of.
I think it more genuine to criticize, then say see I told you so. No one likes to be told they were warned....I just haven't seen it. Business acumen requires that kind of wisdom.
Will the complaining end, or will the sounds of this drum go on in perpetuity. The timing is canny. I mean we appear to be close to good things, and now we rip into the guy, while saying we are going to succeed. Just trying to either figure out why or understand the end game. A businessman would stop the dance and be able to be clear here. Is the end game to see Kim gone, or just beat on the drum until the company is sold. You judge what is most likely to occur, then hopefully rethink allowing the path to be just a little more enjoyable. Sorry, just weary of the repetition.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM